A POPULATION PHENOTYPING STUDY ON SIX (FIVE) DRUG-METABOLIZING ENZYMES AND THE THERAPEUTIC RELEVANCE.

关于六(五)种药物代谢酶及其治疗相关性的群体表型研究。

基本信息

  • 批准号:
    11672267
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Aim #1 : We determined whether the two probe drugs, caffeine and phenytoin, could be simultaneously administered as a cocktail test to estimate three cytochromes P450 (CYP1A2, 2C9 and 2C19), N-acetyltransferase (NAT2), xanthine oxidase (XO) and flavin-containing monooxygenase (FMO) enzyme activities in vivo. in 1999.Methods : Twenty-nine healthy volunteers (14 men and 15 women) received orally 150 mg of caffeine and 100 mg of phenytoin separately and in combination using a 3x3 Latin square. The activities of CYP1A2, NAT2 and XO were expressed by urinary caffeine metabolic ratios, and those of CYP2C9 and 2C19 by phenytoin chiral metabolite ratios.Results : Ascertaining the separate and cocktail phenotyping tests for caffeine correlated with each other, but that for phenytoin did not.Aim #2 : Based on the results of Aim #1, caffeine phenotyping test was extended to assess in vivo activities of five drug-metabolizing enzymes, CYP1A2, NAT2, XO, FMO and CYP2A6 in Kyushu, Japan, in 2000.Methods : One hundred eighty-two healthy volunteers (108 men and 74 women) received an oral 150-mg dose of caffeine before sleep, then overnight urine sample was collected and the concentrations of caffeine and its metabolites were analyzed by HPLC.The enzyme activities were expressed by urinary caffeine metabolic ratios.Results : Frequency distributions of CYP1A2, FMO, and CYP2A6 activities were unimodal, whereas those of NAT2, and XO activities were trimodal and bimodal, respectively. The CYP1A2 activity was statistically higher in smokers than in non-smokers (p<0.0001). The frequency of slow acetylators was 11%. The activities of CYP1A2 and XO were statistically higher (p<0.01), and that of NAT2 was lower (p<0.02) in males than in females. A few subjects showed significantly low activities of CYP1A2, XO, FMO, and CYP2A6. We are currently determining the genotypes of these enzymes and will determine the therapeutic relevance.
Aim #1 : We determined whether the two probe drugs, caffeine and phenytoin, could be simultaneously administered as a cocktail test to estimate three cytochromes P450 (CYP1A2, 2C9 and 2C19), N-acetyltransferase (NAT2), xanthine oxidase (XO) and flavin-containing monooxygenase (FMO) enzyme activities体内。 1999年。方法:29名健康志愿者(14名男性和15名女性)分别接受150毫克咖啡因和100毫克的苯妥英钠,并使用3x3拉丁正方形进行组合。 The activities of CYP1A2, NAT2 and XO were expressed by urinary caffeine metabolic ratios, and those of CYP2C9 and 2C19 b​​y phenytoin chiral metabolite ratios.Results : Ascertaining the separate and cocktail phenotyping tests for caffeine correlated with each other, but that for phenytoin did not.Aim #2 : Based on the results of Aim #1, caffeine phenotyping test was extended to assess in vivo activities of five drug-metabolizing enzymes, CYP1A2, NAT2, XO, FMO and CYP2A6 in Kyushu, Japan, in 2000.Methods : One hundred eighty-two healthy volunteers (108 men and 74 women) received an oral 150-mg dose of caffeine before sleep, then overnight urine sample was collected and the通过HPLC分析咖啡因及其代谢产物的浓度。酶活性通过尿咖啡因代谢比表达。分子:CYP1A2,FMO和CYP2A6活性的频率分布是单模型的,而Nat2和XO活动的频率分布是Trimodal和Bimodal的频率分布。吸烟者的CYP1A2活性在统计学上高于非吸烟者(p <0.0001)。缓慢的乙酰剂的频率为11%。 CYP1A2和XO的活性在统计学上更高(p <0.01),而男性的Nat2的活性比女性低(p <0.02)。一些受试者的CYP1A2,XO,FMO和CYP2A6的活性显着较低。我们目前正在确定这些酶的基因型,并将确定治疗性相关性。

项目成果

期刊论文数量(83)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hamaoka N, et al.: "Propofol decreases the clearance of midazolm by inhibiting CYP3A4 : An in vivo and in vitro study."Clin Pharmacol Ther. 66. 110-117 (1999)
Hamaoka N 等人:“异丙酚通过抑制 CYP3A4 降低咪达唑姆的清除率:一项体内和体外研究。”Clin Pharmacol Ther。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
石崎高志,越前宏俊,古家恵子: "薬物の副作用と相互作用:(多賀須幸男ら編集)今日の治療指針2000"医学書院、東京. 1159-1280 (2000)
Takashi Ishizaki、Hirotoshi Echizen、Keiko Furuya:“药物副作用和相互作用:(由 Yukio Tagasu 等编辑)今日治疗指南 2000”Igakushoin,Tokyo 1159-1280 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Zhao X-J and Ishizaki T.: "A further interaction study of quinine with clinically important studs by human liver microsomes : Determinations of inhibition constant (ki) and type of inhibition."Eur J Drug Metab Pharmacokinet. 24. 272-278 (1999)
赵X-J和石崎T.:“通过人肝微粒体进行奎宁与临床重要研究的进一步相互作用研究:抑制常数(ki)和抑制类型的测定。”Eur J Drug Metab Pharmacokinet。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kudo S,Okumura H,Miyamoto G and Ishizaki T: "Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine"Drug Metab Dispos. 27. 303-308 (1999)
Kudo S、Okumura H、Miyamoto G 和 Ishizaki T:“细胞色素 P-450 异构体参与普拉地平 Hantzsch 吡啶酯的羧酸酯裂解”Drug Metab Dispos。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kudo S and Ishizaki T.: "Pharmacokinetics of haloperidol : An update."Clin Pharmacokinet. 37. 435-456 (1999)
Kudo S 和 Ishizaki T.:“氟哌啶醇的药代动力学:更新。”Clin Pharmacokinet。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIZAKI Takashi其他文献

ISHIZAKI Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIZAKI Takashi', 18)}}的其他基金

Verification of the L1 and L2 information processing model using a computer-controlled verbal-response Stroop test
使用计算机控制的言语反应斯特鲁普测试验证 L1 和 L2 信息处理模型
  • 批准号:
    17K02965
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a computer-controlled verbal-response Stroop test
计算机控制言语反应斯特鲁普测试的开发
  • 批准号:
    23652129
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research

相似国自然基金

DNA序列多态性和转录本m6A修饰影响植物种内差异化环境适应性的分子调控机制的多维度解析
  • 批准号:
    32370707
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
EBNA1多态性关联SUMO修饰在EB病毒潜伏感染和致瘤中的作用
  • 批准号:
    82372242
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于miR-618基因多态性调控TIMP1/MMP9平衡的益肾达络饮治疗多发性硬化作用机制研究
  • 批准号:
    82374365
  • 批准年份:
    2023
  • 资助金额:
    73 万元
  • 项目类别:
    面上项目
基于OATP1B3基因多态性和miRNA介导表观遗传调控的罕见病用药米托坦片个体化用药研究
  • 批准号:
    82304638
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
图们江流域中国边境地区候鸟-蜱-蜱携带病原流行病学数据库的建立及候鸟对蜱携带病原体多态性影响机制研究
  • 批准号:
    32360886
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Testing evolutionary hypotheses for the long-term maintenance of balanced immunogenetic polymorphisms in a wildlife model
在野生动物模型中测试长期维持平衡免疫遗传多态性的进化假设
  • 批准号:
    NE/Y000900/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
CAREER: CRISPR-based biosensors for the ultra-accurate detection of disease-related single nucleotide polymorphisms (SNPs)
职业:基于 CRISPR 的生物传感器,用于超准确检测与疾病相关的单核苷酸多态性 (SNP)
  • 批准号:
    2421137
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Continuing Grant
CAREER: CRISPR-based biosensors for the ultra-accurate detection of disease-related single nucleotide polymorphisms (SNPs)
职业:基于 CRISPR 的生物传感器,用于超准确检测与疾病相关的单核苷酸多态性 (SNP)
  • 批准号:
    2339868
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Continuing Grant
Integrated analysis of single nucleotide polymorphisms associated with "nonsyndromic" cleft lip and palate
与“非综合征”唇腭裂相关的单核苷酸多态性的综合分析
  • 批准号:
    23K09149
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Itch-specific brain circuit and dopaminergic gene polymorphisms influencing individual differences in itch perception
瘙痒特异性脑回路和多巴胺能基因多态性影响瘙痒感知的个体差异
  • 批准号:
    10735592
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了